Christopher Shryock Sells Shares of Medline Inc. $MDLN

Key Points

  • Christopher Shryock sold 872 shares of Medline Inc. ($MDLN) worth $31,923.92.
  • $MDLN last traded around $37.09.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Christopher Shryock, Chief Human Resources Officer at Medline Inc. ($MDLN), sold 872 shares at an average price of $36.61, for a total transaction of $31,923.92. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.

Medline Inc. Stock Up 5.1%

Shares of Medline Inc. ($MDLN) traded around $37.09 on Wednesday, up 5.1% for the day.

Last price$37.09
Market cap$30.73B
P/E ratio43.79
Forward P/E22.14
52-week low$32.48
52-week high$50.88
50-day MA$37.77
200-day MA$41.14
Current ratio4.33
Quick ratio2.45
Debt-to-equity0.66

Medline Inc. Earnings

EPS (ttm)$0.80
Revenue (ttm)$29.94B
Revenue growth11.60%
Net margin2.31%
Return on equity4.93%
Next earningsNov 4, 2026

Analysts Set New Price Targets

ConsensusBuy
Average target$44.62
High target$55
Low target$34
Analysts covering26

About Medline Inc.

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.

ExchangeNasdaqGS
SectorHealthcare
IndustryMedical Instruments & Supplies
HeadquartersNorthfield, IL
CEOMr. James M. Boyle
Employees45,000

Get Medline Inc. alerts

New 13F filings, insider trades, and analyst moves on $MDLN, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.